课题基金 / 基金详情

NEUROCHEMICAL ANALYZER

NEUROCHEMICAL ANALYZER
神经化学分析仪
批准号:
3520236
负责人:
Philip Joseph Langlais
金额:
$10.7万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-05-10 至 1990-05-09

项目摘要

项目成果

Philip Joseph Langlais的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Members of the Department of Neurosciences at the School of Medicine are currently conducting PHS funded clinical and basic research programs concerning the mechanisms and treatment of degenerative central nervous system diseases including Alzheimer's disease, Parkinsonism, epilipsy as well as studies of normal aging. A major aspect of these studies involves neurotransmitter, neuropeptide, amino acid, and drug analyses using high-performance liquid chromatography, electrochemical detection (HPLC-EC) instrumentation. The majority of assays have been provided through collaborative arragnements with investigators at nearby institutions. Current and future human and animal model studies, however, involve larger numbers of samples and the need to measure other important neurochemical or drug substances, thus rendering these collaborative arrangements impractical and inadequate. The need exists for an instrument with superior analytical resolution to accurately assay complex biological tissues (e.g., human brain, CSF, and plasma) and at the same time be able to process large numbers of samples. The Neurochem Neurochemical Analyzer (NCA), an HPLC-EC instrument recently developed by ESA, Inc. uniquely fulfills these criteria. Funds are requested to purchase the NCA to serve as a departmental "core" apparatus for the shared use of its funded investigators. Unlike other HPLC-EC systems, the NCA combines: i) a superior analytical resolution through its unique array of 16 electrochemical detectors; ii) capability of quantifying over 80 compounds in a single 45 mins run; iii) high volume capacity through its refrigerated 100 sample autosampler and computer driven, 24 hr (overnight) unattended operation; and iv) routine sensitivity in the mid femtogram (5 X 10-13) range. A five member internal advisory board will oversee its use. During the first two years the three major user will utilize 100% of this instrument's time based on a 24 hr, five day work week. In subsequent years, as time becomes available, eight other departmental investigators will be permitted to use this instrument for neurochemical analyses involved in their research projects. The PI has extensive experience in the development of analytical methods using HPLC-EC instruments and will train and supervise the users' technicians in the operation and use of the NCA.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Effects of NBm lesions on T-maze performance and thalamic biochemistry.
NBm 损伤对 T 迷宫性能和丘脑生物化学的影响。
DOI: 10.1016/0197-4580(93)90036-b
发表时间: 1993
期刊: Neurobiology of aging
影响因子: 4.2
作者: [Connor,DJ, Langdon,DJ, Langlais,PJ, Thal,LJ]
通讯作者: Thal,LJ
Comparison of the effects of single and combined neurotoxic lesions of the nucleus basalis magnocellularis and dorsal noradrenergic bundle on learning and memory in the rat.
大细胞核和背侧去甲肾上腺素束的单一和联合神经毒性损伤对大鼠学习和记忆的影响的比较。
DOI: 10.1016/0166-4328(93)90050-z
发表时间: 1993
期刊: Behavioural brain research
影响因子: 2.7
作者: [Langlais,PJ, Connor,DJ, Thal,L]
通讯作者: Thal,L
Independent effects of age and nucleus basalis magnocellularis lesion: maze learning, cortical neurochemistry, and morphometry.
年龄和大细胞基底核病变的独立影响:迷宫学习、皮质神经化学和形态测量。
DOI: 10.1037//0735-7044.106.5.776
发表时间: 1992
期刊: Behavioral neuroscience
影响因子: 1.9
作者: [Connor,DJ, Thal,LJ, Mandel,RJ, Langlais,PJ, Masliah,E]
通讯作者: Masliah,E
HISTAMINE GLUTAMATE INTERACTION IN WERNICKE LESIONS
  • 批准号:
    2735641
  • 项目类别:
  • 资助金额:
    $19.56万
  • 财政年份:
    1995
  • 负责人:
    Philip Joseph Langlais
  • 依托单位:
HISTAMINE, IL-1 & NITRIC OXIDE IN WERNICKE LESIONS
  • 批准号:
    6330476
  • 项目类别:
  • 资助金额:
    $21.4万
  • 财政年份:
    1995
  • 负责人:
    Philip Joseph Langlais
  • 依托单位:
HISTAMINE, IL-1 & NITRIC OXIDE IN WERNICKE LESIONS
  • 批准号:
    6477349
  • 项目类别:
  • 资助金额:
    $22.02万
  • 财政年份:
    1995
  • 负责人:
    Philip Joseph Langlais
  • 依托单位:
HISTAMINE, IL-1 & NITRIC OXIDE IN WERNICKE LESIONS
  • 批准号:
    6051067
  • 项目类别:
  • 资助金额:
    $20.77万
  • 财政年份:
    1995
  • 负责人:
    Philip Joseph Langlais
  • 依托单位: